Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Mar 14
Is It Time to Redefine Prognostic and Predictive in Oncology?
Related Questions
Given the importance of minimizing financial toxicity, for patients who have borderline unfavorable intermediate characteristics, is it reasonable to ...
New answer by Radiation Oncologist at National Institutes of Health Clinical Center (November 4, 2024)
Summary: The short answer is that APP4 is unlikely to improve risk prognostication to the extent to which other advanced biomarkers (GC, MMAI, etc.) do. It is also unlikely ei...